ClinicalTrials.gg
RecruitingNCT07345572eTREUpdated Aug 13, 2026

Investigating the Impact of Early Time-Restricted Eating on Health Outcomes and Quality of Life in Adults With Mild Controlled Asthma Compared to Healthy Adults

An interventional study of Early Time-Restricted Eating (eTRE) and Habitual Diet (HD) and Habitual Diet (HD) and Early Time-Restricted Eating (eTRE) in Asthma Management and Time Restricted Eating, sponsored by De Montfort University. Recruiting at 1 site in United Kingdom. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-08-13.

Sponsored by De Montfort University · Not applicable, Interventional, and Other

From the registry’s dates

  • Started Feb 2026; still recruiting 8 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
36
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

This study aims to explore how early time-restricted eating (eTRE) - where all daily meals are eaten within a specific time window - affects health and quality of life in adults. The researchers will compare results between adults with mild, well-controlled asthma and adults without asthma (non-asthma group). Participants can continue to eat their normal food; only the timing of meals will change.

Read the detailed description

During the study, participants will be asked to:

  • Follow an early time-restricted eating schedule for one week and their usual eating schedule for another week while keeping to their usual diet.
  • Attend four visits to the research facility on campus.
  • Provide saliva, blood, and urine samples for health marker analysis.
  • Complete breathing tests (spirometry and FeNO) to measure lung function.
  • Complete short questionnaires about physical activity, chronotype, and quality of life.
  • Take part in a short interview about their asthma symptoms and quality of life.
  • Keep a brief food diary each week.
  • Provide details of any medications they currently take.
02

Conditions studied

  • Asthma Management
  • Time Restricted Eating

Keywords

  • Asthma
  • time restricted eating
  • inflammatory markers
  • oxidative stress markers
  • pulmonary function parameters
  • quality of life
  • adherence
03

In context

Intermittent Fasting

333 studies on the registry are indexed under Intermittent Fasting; 99 are open to participants now.

This study's planned enrollment of 36 is below the median of 50 across 320 interventional studies indexed under Intermittent Fasting.

Browse Intermittent Fasting studies →

Lead sponsor

De Montfort University is the lead sponsor of 2 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults between 18 and 65 years old.
  • Non asthma group: individuals without asthma
  • Asthma group: Have already been diagnosed with controlled mild asthma.
  • Not following any diet regimen.
  • Able to read the information pack and give consent in English.

Exclusion criteria

Exclusion Criteria:

  • Moderate to severe asthma
  • Pregnant
  • Smoking
  • Systemic .
  • History of recent respiratory disease, current chest infection, and collapsed lung.
  • History of recent surgery (last 2 months), including thoracic, abdominal, and eye surgery.
  • Being diagnosed with cardiovascular diseases, e.g., unstable angina, a heart attack, uncontrolled high blood pressure, stroke, and aneurysm.
  • Broken ribs or neck vertebrae.
  • Cancer.
  • History of diseases
  • Being diagnosed with an eating disorder.
  • Overnight shift work
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

Autoimmune disease

A condition in which the immune system attacks the body’s own tissues, such as rheumatoid arthritis, lupus, psoriasis, type 1 diabetes or inflammatory bowel disease.

Immunotherapy studies often leave out active autoimmune disease, and some name exceptions, such as thyroid disease on replacement hormone. Check the exceptions this study lists.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
36 participants (estimated)

Study arms

  • Active comparator
    Habitual Diet (HD) and early Time Restricted Eating (eTRE)

    The participants will be asked to follow their habitual diet for one week. After a minimum of two weeks washout period, the participants will be assigned to eTRE and asked to eat from 8 am to 4 pm without restriction on the quantity or amount of food and fast for the rest of the time except for drinking water for one week.

    Other: Habitual Diet (HD) and Early Time-Restricted Eating (eTRE)

  • Active comparator
    early Time Restricted Eating (eTRE) and Habitual Diet (HD)

    The participants who are assigned to eTRE will be asked to eat from 8 am to 4 pm without restriction on the quantity or amount of food and fast for the rest of the time except for drinking water for one week. After a minimum of two weeks washout period, participants will be asked to follow their habitual diet for one week.

    Other: Early Time-Restricted Eating (eTRE) and Habitual Diet (HD)

Interventions

  • OtherEarly Time-Restricted Eating (eTRE) and Habitual Diet (HD)

    The participants who are assigned to eTRE will be asked to eat from 8 am to 4 pm without restriction on the quantity or amount of food and fast for the rest of the time except for drinking water for one week. After a minimum of two weeks washout period, participants will be asked to follow their habitual diet for one week.

    Also known as: eTRE

  • OtherHabitual Diet (HD) and Early Time-Restricted Eating (eTRE)

    The participants will be asked to follow their habitual diet for one week. After a minimum of two weeks washout period, the participants will be assigned to eTRE and asked to eat from 8 am to 4 pm without restriction on the quantity or amount of food and fast for the rest of the time except for drinking water for one week.

06

What researchers measure

Primary outcomes

  1. Lung Function Parameters, FEV1 in Liters (L)

    A spirometry test will be conducted to gather information about lung function parameters.

    Time frame: At baseline and after 1 week in each study arm

  2. Lung Function Parameters, FVC in Liters (L)

    A spirometry test will be conducted to gather information about lung function parameters.

    Time frame: At baseline and after 1 week in each study arm

  3. Lung Function Parameters, FEV1/ FVC ratio

    A spirometry test will be conducted to gather information about lung function parameters.

    Time frame: At baseline and after 1 week in each study arm

Secondary outcomes

  1. Blood for health biomarkers

    Changes in plasma-based health biomarkers will be assessed from acellular plasma extracted from venous blood samples to explore physiological responses to the intervention. Biomarker results will be summarized descriptively.

    Time frame: At baseline and after 1 week in each study arm

  2. Urinary Biomarker Profile

    The urinary metabolomics profile will be assessed to explore changes in metabolites associated with the intervention. Results will be summarized descriptively.

    Time frame: At baseline and after 1 week in each study arm

  3. Salivary Metabolomic Profile

    Salivary metabolomics profile will be assessed to explore changes in metabolites associated with the intervention. Metabolomic features will be summarized descriptively.

    Time frame: At baseline and after 1 week in each study arm

  4. Changes in Quality of Life using Asthma Quality of Life Questionnaire (AQLQ)

    The Asthma Quality of Life Questionnaire (AQLQ) will be given to assess changes in quality of life in individuals with asthma.

    Time frame: At baseline and after 1 week in each study arm

  5. Fractional Exhaled Nitric Oxide (FeNO) in parts per billion (ppb)

    Fractional exhaled nitric oxide (FeNO) test will be conducted to gather information about airway inflammation.

    Time frame: At baseline and after 1 week in each study arm

  6. Changes in Quality of Life using PROMIS Global Health v1.2

    The PROMIS Global Health v1.2 will be given to assess changes in quality of life for individuals without asthma.

    Time frame: At baseline and after 1 week in each study arm

  7. Changes in asthma control using Asthma Control Questionnaire (ACQ)

    Asthma Control Questionnaire will be given to individuals with asthma to assess their asthma control.

    Time frame: At baseline and after 1 week in each study arm

  8. Semi-structured interview for assessing quality of life and acceptability of interventions.

    A semi-structured interview will be conducted among participants with mild asthma who are assigned to the eTRE group to assess the challenges they faced and their experiences after the eTRE intervention.

    Time frame: After 1 week of eTRE

Other outcomes

  1. A Food Diary Record

    A food diary will be given to record and keep track of participants' diet over three consecutive or non-consecutive days, selected by the participants during the 7 days intervention period.

    Time frame: During the 7-day intervention period (any 3 days)

  2. Adherence Monitoring

    All participants will be given an adherence log to fill out daily as we aim to monitor their adherence. The participant will be reminded every day by email to fill out the log and ensure their adherence to the intervention.

    Time frame: Before eTRE

  3. Demographic Data

    Demographic data such as age, sex and ethnicity.

    Time frame: At baseline

  4. Body weight in kilograms (Kg)

    Calibrated electronic scales will be used to measure body weight in kilograms.

    Time frame: At baseline and after 1 week in each study arm

  5. Height in centimeters (cm)

    A stadiometer will be used to measure height in centimeters.

    Time frame: At baseline and after 1 week in each study arm

  6. Changes in physical activity levels using International Physical Activity Questionnaire (IPAQ)

    IPAQ questionnaire will be given to individuals with and without asthma to assess their physical activity levels.

    Time frame: At baseline

  7. Chronotype assessment using the Morningness-Eveningness Questionnaire (MEQ)

    Morningness-Eveningness Questionnaire will be given to individuals with and without asthma to identify their chronotypes.

    Time frame: At baseline

  8. Body Mass Index (BMI)

    BMI will be calculated using the formula BMI = body weight \[kg\]/ (height \[m\])2.

    Time frame: At baseline and after 1 week in each study arm

07

Study locations

1 of 1 sites recruiting
  • Health and Life Science
    Leicester, England, United Kingdom
    Recruiting
    • Nouf Alotaibi · ContactP2876983@my365.dmu.ac.uk
    • Mariasole Da Boit, Phd · Principal investigator
    • Eleni Karasouli, Phd · Sub investigator
    • Martin Grootveld · Sub investigator
08

References and documents

Individual participant data

Plan to share: No — IPD will not be shared due to institutional policy related to participant confidentiality.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 13, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07345572
Lead sponsor
De Montfort University
Collaborators
King Saud Bin Abdulaziz University for Health Sciences
Responsible party
Nouf Alotaibi (Principal Investigator, De Montfort University) — Principal investigator
First posted
Jan 15, 2026
Start date
Feb 25, 2026
Primary completion
Jul 1, 2027 (estimated)
Completion
Jul 1, 2027 (estimated)
Last update
Aug 13, 2026

Study contacts

Nouf N Alotaibi
Contact
P2876983@my365.dmu.ac.uk
+447852689959

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion